Weighted Average Number of Shares Outstanding, Basic of Cytek Biosciences, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Cytek Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2020 to Q3 2025.
  • Cytek Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 128M shares, a 2.64% decline year-over-year.
  • Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 131M shares, a 3.45% decline from 2023.
  • Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 135M shares, a 0.57% increase from 2022.
  • Cytek Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 135M shares, a 75.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Cytek Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 128M -3.46M -2.64% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 127M -4.51M -3.43% 01 Apr 2025 30 Jun 2025 10-Q 06 Aug 2025
Q1 2025 128M -2.58M -1.97% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 131M -4.67M -3.45% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 131M -5.17M -3.8% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 131M -4.48M -3.3% 01 Apr 2024 30 Jun 2024 10-Q 06 Aug 2025
Q1 2024 131M -4.57M -3.37% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 135M +772K +0.57% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 136M +1.46M +1.09% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 136M +1.52M +1.13% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 135M +1.59M +1.19% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024
Q4 2022 135M +57.8M +75.3% 01 Oct 2022 31 Dec 2022 10-K 28 Feb 2025
Q3 2022 135M +26.4M +24.4% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 134M +103M +322% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 134M +102M +324% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 76.7M 01 Oct 2021 31 Dec 2021 10-K 13 Mar 2024
Q3 2021 108M +79.6M +277% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 31.9M +3.38M +11.9% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 31.6M 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q3 2020 28.7M 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 28.5M 01 Apr 2020 30 Jun 2020 10-Q 03 Sep 2021

Cytek Biosciences, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 131M -4.67M -3.45% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 135M +772K +0.57% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 135M +57.8M +75.3% 01 Jan 2022 31 Dec 2022 10-K 28 Feb 2025
2021 76.7M +47.6M +163% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2024
2020 29.1M 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.